Cell-cell and cell-matrix interactions play critical roles in various developmental processes including differentiation, proliferation, and migration. Members of the integrin family of cell surface components are important mediators of these cell-extracellular matrix (ECM) contacts or interactions. The ECM provides signals to individual cells essential for development and differentiation and plays essential roles in establishing and maintaining the complex structure of the vertebrate heart. Integrins provide a fundamental link for transduction of developmental signals to cells. Integrin expression by cardiac myqtes is altered during neonatal heart development and disease; however, little is known regarding the spatial and temporal patterns of integrin expression during embryonic and fetal heart development. Essential to understanding the role of integrins in the organization of the heart, the present studies have localized 0-1 integrin protein and mRNA in fetal and neonatal rat hearts. b1 integrin is predominantly found in regions of remodeling (trabeculae) in the early heart (10-13 days of gestation). Later in development (15 days of gestation onward), b1 integrin is abundant in regions containing an elaborate ECM, such as the valves. These studies further support the hypothesis that the expressions of integrins and ECM are coordinately regulated in the developing heart. ( J Hisrochem Cytochem Literature Cited Albelda SM, Buck CA (1990): Integrins and other cell adhesion molecules. FASEB J 4:2868 Bissell MJ, Hall HG, Parry G (1982): How does the extracellular matrix direct gene expression? J Theor Biol 99:31 Borg TK, Caulfield JB (1979): Collagen in the heart. Texas Rep Biol Med 39:321 Borg TK, Gay R, Johnson TK (1983): Changes in the distribution of fibronectin and collagen during the development of the neonatal heart. Col1 Relat Res 2:2111 Borg TIC, Raso DS, Terracio L (1990a): Potential role of the extracellular matrix in the postseptation development of the heart. Ann NY Acad Sci 588:87 Borg TK, Terracio L (1990): Interaction ofthe extracellular matrix with cardiac myocytes during development and disease. In Robinson T. ed. Issues in biomedicine. Basel, Karger, 113 Borg TK, Xuehui M, Hilenski L, Vinson N, Terracio L (199Ob): The role of the extracellular matrix on myofibrillogenesis in vitro. In Clark EB, WO A, eds. Developmental cardiology: morphogenesis and function. Mount Kisco, NY, Futura Publishing, 175
Introduction
Integrin-mediated cell-matrix interactions are thought to play critical roles in embryonic development, wound healing, and normal tissue maintenance (Hynes, 1987 (Hynes, ,1992 Rouslahti, 1991; Albelda and Buck, 1990; Buck and Horwitz, 1987; Bronner-Fraser, 1985 , 1986 . Interactions of cells with the surrounding extracellular matrix (ECM) influence various developmental processes including cell proliferation, biosynthesis, and differentiation (Menko and Boettiger, 1987; Ekblom et al., 1986; Bissell et al., 1982) . The integrin superfamily is significant in the interactions of most cells with extracellular matrix (ECM) components.
Integrins are heterodimers of noncovalently linked aand P-chains which form a transmembrane complex linking the ECM outside of the cell to the cytoskeleton inside. The P-chains can complex with any of several specific a-chains which are thought to confer ECM ligand specificity to the integrin (Albelda and Buck, 1990; Humphries, 1990) .
Integrins are expressed in precise spatial and temporal patterns during organogenesis of various systems (Korhonen et al., 1990) . The p-1 integrins are abundantly expressed in the neonatal heart Borg et al., 1990a) , the expression of specific a-chains associated with the p-1 integrin family is altered in neonatal development and hypertrophy of the heart , and p-1 integrins are abundantly stained along the 2-bands of neonatal myocytes in vitro (Hilenski et al., 1989 (Hilenski et al., ,1991 Borg et al., 1990b) . Recent studies have shown that p-1 integrins play a critical role in adhesion to ECM components, spreading, and myofibrillogenesis of isolated heart myocytes (Hilenski et al., 1992) . However, very little is known regarding the distribution and role of integrins in the developing heart in vivo.
This study examined the spatial and temporal patterns of expression of p-1 integrin in the fetal and neonatal heart. Immunohistochemical staining and in situ hybridization were used to characterize the distribution of p-1 integrin protein and mFWA by light microscopy (LM). Immunoelectron microscopy (IEM) was used to examine the distribution of D-1 integrin on the surface of heart cells during development. These studies clearly show the localization of p-1 integrin over most cells of the heart early in development (10-13 days of gestation). Later in development (15 days of gestation to neonate), staining is most abundant in the valve regions and endocardial cells. Supported by NIH grants HL.37669, HL24935, HL42249, and To whom correspondence should be addressed.
HL40424.

Materials and Methods
Northern Blot Analysis. Poly-A mRNA was extracted from rat hearts with the Invitrogen Fast Track system (Invitrogen; San Diego, CA), size-fractionated on 1.1% agarose gels containing formaldehyde (Sambrook et al.. 1989) . and transferred to Duralon membranes (Stratagene; La Jolla, CA) by capillary diffusion (Sambrook et al., 1989) . Blots were pre-hybridized for 1 hr at 42°C in 5 x SSPE [standard saline, phosphate, ethylenediamineretraceric acid buffer (EMA) (20 x SSPE is 3.6 M sodium chloride, 0.2 M sodium phosphate, 0.02 M EMA, pH 7.4). 50% formamide, 10% dextran sulfate. 2 x Denhardt's, 100 pglml salmon sperm DNA, and 0.1% sodium dodecyl sulfate (SDS)]. After pre-hybridization, blots were hybridized to j2P random-primed (Stratagene Prime It Kit) p-1 integrin cDNA probe for 16 hr at 42'C. Hybridization was carried out in the same solution as pre-hybridization. After hybridization, blots were rinsed twice at room temperature (RT) in 2 x SSC (standard saline citrate buffer; 1 x SSC is 0.15 M sodium chloride, 0.015 M sodium citrate, pH 7). 0.1% SDS, then twice at 65°C in 1 x SSC, 0.1% SDS. Blots were then exposed to Kodak X-Omat X-ray film for 24-48 hr.
Immunohistochemistry. Timed-pregnant Sprague-Dawley rats were sacrificed at appropriate stages by CO2 asphyxiation and fetal animals removed from the uterus. Animals were staged according to morphological criteria (Brown and Fabro, 1981) . For animals used after birth, hearts were isolated at appropriate ages post partum. Either whole embryos (10.5-13 days' gestation) or isolated hearts were fixed for 2-4 hr in 2% paraformaldehyde in PBS. Fixative was quenched by rinsing tissues several times in 1% glycine in PBS. Tissues were rinsed, dehydrated. cleared in xylene, and embedded in paraffin. Sections 5-7 pm were placed on glass slides and heated (55'C) to adhere the section to the slide. Sections were deparaffinized and rehydrated through a graded series of ethanol to PBS. Endogenous peroxidase activity in the tissue sections was quenched in 2.1% H202 in merha-no1 for 30 min. Sections were further blocked in non-immune serum and 1% bovine serum albumin in PBS for 1 hr. Tissue sections were incubated in a B-1 integrin polyclonal antiserum (Hilenski et al., 1991; Terracio et al., 1991) overnight at 4'C. then rinsed several times in PBS containing 1% bovine serum albumin and incubated in Vectastain ABC reagent (Vector Laboratories; Burlingame, CA). Sections were rinsed further and bound antibody was detected by incubation of the sections in 0.05% DAB with 0.03% H202. Controls for immunohistochemical staining included omission of the primary antibody and substitution of pre-immune serum for the primary antibody. Only staining due to endogenous peroxidase activity in red blood cells was seen with the control sections.
In Situ Hybridization. Whole embryos or isolated hearts were fixed for 4 hr in 4% paraformaldehyde in PBS at 4'C. Tissues were rinsed several times in PBS, dehydrated through a graded series of ethanols. cleared in xylene, and embedded in paraffin. Glass slides for mounting sections were treated with chromic acid and rinsed for several hours in water. Slides were incubated overnight in 1% aminopropyltrielhoxysilane (Sigma; St Louis, MO). Slides were rinsed in water, treated with 0.5% glutaraldehyde for 30 min, rinsed again in water, and treated with 0.1 M sodium m-periodate for 1 hr. Slides were rinsed in 0.1 M sodium phosphate, rinsed in water, and baked overnight to eliminate potential RNAse contamination.
Tissue sections mounted on treated slides were deparaffinized in xylene and rehydrated through a descending series of ethanols to 0.2 N HCI. Sections were incubated in 2 x SSC at 70°C. Tissue sections were then treated with 2 pglml proteinase K and acetylated (Hayashi et al., 1978) before hybridization. Sections were dehydrated and hybridized to 35Slabeled mouse D-1 integrin or human al(1) collagen cDNA probes overnight at 42'C. After hybridization, sections were rinsed in 2 x SSC, 50% formamide. 50 mM 2-mercaptoethanol at 50'C twice for 30 min each and in 2 x SSC. 50 mM 2-mercaptoethanol at 45°C twice for 30 min each. Sections were dehydrated through an ascending series of ethanols containing 300 mM ammonium acetate and were air-dried. Sections on glass slides were then coated with llford K.5D emulsion and exposed for 3 days to 2 weeks at 4°C. Slides were developed, fixed, and stained with hematoxylin and eosin. They were examined with a Zeiss IM 35 microscope equipped with a darkfield condensor.
cDNA Probes. The p-1 integrin cDNA probe used in these studies corresponded to the COOH terminal 900 BP of mouse B-1 integrin (a generous gift from Dr. C.A. Buck, Wistar Institute, Philadelphia. PA). The cDNA was subcloned into the EcoRl site of the pGEM-I vector (Promega; Madison, WI). For in situ hybridization the vector was digested with EcoRl and the D-1 cDNA isolated by agarose gel electrophoresis. The cDNA was purified from the agarose gel with the Qiaex gel purification system (Qiagen; Chatsworth, CA). The cDNA was random prime-labeled with [ "SI-dCTP (Prime-It: Stratagene) and purified with NucTrap columns (Stratagene).
Human al(1) collagen cDNA was obtained from Dr. E. Vuorio (University of Finland, Turku. Finland). Restriction fragments of the al(1) clone were used such that cross-hybridization to other collagen chains did not occur (Carver et al., 1903; Sandberg et al., 1989) . Control sections were hybridized to a fragment of the pGEM 1 vector (Promega) of approximately the same length and specific activity as the p-1 integrin probe. These probes were purified and labeled as described above for the B-1 integrin cDNA. No areas containing significant hybridization were seen in control sections.
Immunoelectron Microscopy. Tissues were processed as previously described (Price et al., 1992; Martins-Green and Tokuyasu, 1988) . Three hearts at each developmental stage were dissected in cold Tyrode's solution. At 11.5 days' gestation the entire heart was used, as the areas of the heart could not be separated. In later developmental stages specific areas of the heart were dissected and fixed. Each area of the heart examined was minced into I-mm pieces and fixed for 2 hr at RT in 4% paraformaldehyde, 0.2% glutaraldehyde in Sorenson's phosphate buffer, pH 7.4. After fixation tissues are rinsed in PBS buffer containing 0.02 M glycine, 0.002% Triton X-100, and 0.02% sodium azide (PBSS buffer) for 30 min at 22'C, and in three further changes of PBSS for 2-3 hr each at 4°C. Tissues were then incubated for 12 hr at 4'C in anti-p1 integrin lgGs (50 pglml) diluted in PBSS. rinsed in three changes of PBSS at 4'C at 2-hr intervals, and incubated in goat anti-rabbit IgGs conjugated to 5-nm gold (1:25 dilution) for 12 hr at 4'C. Control tissues were incubated in PBSS without primary antibodies. No gold localization was observed on control sections at any of the developmental stages. After incubation in secondary antibodies, tissues were rinsed in three changes of PBSS at 2-hr intervals at 4'C. fixed in 2.5% glutaraldehyde in Sorenson's phosphate buffer, post-fixed in 2% 0~0 4 , ethanol-dehydrated, and embedded in PolylBed 812 (Polysciences; Warrington. PA). Sections (0.25 pm by interference colors) were stained with 2% aqueous uranyl acetate and Reynolds' lead citrate (Reynolds, 1963) and viewed on a JEOL 2OOCX EM at 160 and 200 kV. Care was taken to observe only sections of the same thickness at the various developmental stages.
Antibodies. Production and characterization ofantibodies to p-1 integrin from rat hearts haw been described previously . These antibodies react with only the 8-1 integrin protein by immunoprecipitation. stain specific regions of heart myocytes and fibroblasts (Hilen- 
Results
Northern Blot Analysis .
Northern blot analysis was performed to confirm that the cDNA probe used in these studies hybridized to the correct mRNA transcript in the rat heart. Hybridization of 5 pg rat heart mRNA to the random-primed mouse p-1 integrin cDNA revealed a single transcript of approximately 4.6 KB (Figure 1 ). This is in close agreement with reports of others for p-1 integrin mRNA (Dedhar, 1989) .
(rl integrin mRNA was present at all stages examined.
Early Fetal Development
Sections of 11-11.5 day fetal hearts stained with antibodies to p-1 integrin showed intense localization in myocytes of the trabeculae and less intense localization on cells of the compact myocardium and cardiac cushions (Figures 2a-2c and ultrastructural localization of b-1 integrin indicated that localization was restricted to the cell surface (Figures 2b-2d ). Ultrastructural localization was in distinct patches along the myocyte plasma membrane (Figure 2d ). In situ hybridization with the b-1 integrin cDNA confirmed the pattern of immunohistochemical localization at this stage of development (Figure 3 ). Low-magnification micrographs showed that most cardiac cells, including those of the myocardium and cardiac cushions, produced p-1 integrin mRNA (Figures 3a-3c) . As in the immunohistochemical localization. differences were noted in the intensity of hybridization of cells in different regions of the 11.5-day heart. Cells of the developing trabeculae and compact myocardium contained higher densities of grains than cells of the cardiac cushions (Figures 3a-3c ). This distribution reflected that for the protein staining described above (Figure 2) .
Late Fetal and Neonatal Development
By 15-16 days ofdevelopment, immunohistochemical staining was predominantly in the cardiac cushions and outflow regions ( Figure  4a ). Ultrastructurally, endocardial cells of the valves were heavily stained in areas of cell junctions (Figure 4b ) and areas presumed to be sites of receptor-mediated endocytosis (Figure 4c ). Localization of p-1 integrin was less apparent in the compact cells of the myocardium, but when present the heaviest staining was in areas where cells were closely apposed (Figure 4d ) and in areas where collagen contacted the surface of developing myocytes (Figure 4e ).
In late fetal (18-20 days' gestation) and neonatal stages of development, intense immunohistochemical staining was seen on the surfaces of cells in the valve leaflets (Figure sa) . In situ hybridization of neonatal heart sections also demonstrated abundant 0-1 integrin mRNA in cells of the heart valves ( Figure Sb) and lining the chambers of the neonatal heart (Figures 5c and 5d ). Conversely, hybridization with an a(1)I collagen cDNA probe revealed most abundant signal in scattered cells within the heart wall, believed to be heart fibroblasts (Figures 6a and 6b) . Ultrastructurally, localization of P-1 integrin on neonatal heart myocytes was similar to that observed at 16 days of development, with concentrations of staining in areas of cell-cell interaction and in areas of morphological specialization such as 2-bands ( Figure 6c ).
Discussion
Integrins are associated with various developmental processes including cell migration, proliferation, and differentiation (Bronner-Fraser, 1985 ,1986 , and integrin-ECM interactions play critical roles in development, maintenance, and pathology of the heart (Borg and Terracio, 1990) . The studies presented here correlate the spatial and temporal distribution of p-1 integrin expression with specific morphogenetic events that occur in the developing rat heart. p-1 integrin was found over most cells of the heart at 10-13 days of gestation, with the most intense staining over myocytes of the developing trabeculae, which correlates with the dramatic morphogenesis of these regions during early heart development. Later in development (15 days' gestation-neonate), staining for p-1 integrin became much more intense over connective tissue cells of the developing heart valves and outflow regions, which correlates with histogenesis and condensation of the valves. Ultrastructural evidence (unpublished) indicates that this pattern of differential expression of p-1 integrins closely follows the pattern of myofibrillogenesis in the developing heart, which occurs first in the ventricles, followed by the atria and outflow tract.
Changes in the distribution of P-1 integrin temporally and spatially parallel the secretion and accumulation of specific ECM components during heart development. Early in development, cells in the trabeculae produce the basement membrane components laminin and Type IV collagen (Raso et al., unpublished observations) . Laminin distribution becomes more extensive as morphogenesis of the heart proceeds, changing from isolated punctate patches in early development to more extensive areas in the basement membrane of late fetal, neonatal, and adult hearts (Price et al., 1992) . Similarly, IEM staining of p-1 integrin is initially seen as patches of gold particles on the cell surface. However, it is impossible with this technique to determine the three-dimensional organization of the ECM components or integrins on the cell surface.
Surprisingly, IEM label was seen not only on the surface of heart cells but also some distance away from the surface. Although the epitopes recognized by the P-1 integrin antibodies used in our study are not known, the antibodies may recognize regions of the large extracellular domain of the P-1-chain. This, combined with the indirect labeling protocol used in these studies, could explain this labeling pattern. Experiments are under way with antibodies to the 6-1 integrin cytoplasmic domain to attempt to verlfy this.
This and other studies indicate the coordinated expression of ECM components and their integrin receptors. Expression of fibronectin and interstitial collagens increases in the developing rat heart Borg et al., 1983; Borg and Caulfield, 1979) . In late embryonic and neonatal stages, when p-1 integrin expression is most obvious in the valves, fibroblasts in these areas synthesize interstitial collagens which are organized into a three-dimensional network (Borg and Caulfield, 1979) . Increased ultrastructural localization of p-1 integrin at areas of morphological specialization and greatest mechanical stress, such as 2-bands and in areas where collagen attaches to cardiac myocytes, emphasizes the relationship between integrins and ECM components and the role mechanical stimulation may play in the expression and distribution of these components . Chemical factors, including metalloproteinases, growth factors, and cyrokines, also regulate the organization and interactions of ECM components, integrins, and intracellular development (Nakagawa et al., in press; Milam et al., 1991; Werb et al., 1989) .
The P-1 integrin chain can form a functional integrin complex with at least eight different a-chains (Albelda and Buck, 1990) . thus conferring ECM ligand specificity to the integrin complex. Several of the a-chains also have alternatively spliced variants which may have different functions ( k u r a et al., 1991). Molecular probes and antibodies are becoming available to examine the expression and role of specific a-chains of the p-1 integrin subfamily (Ignatius et al., 1990) . Terracio et al. (1991) have reported that the a-1-chain increases in the fetal and neonatal heart concurrent with increased ECM accumulation. Recent data illustrate that cytoplasmic domains of the a-chains, which are significant in integrin-cytoskeleton interactions, may play critical roles in the determination of cell phenotype (Chan et al., 1992) . It will be essential to define the patterns of expression and role of the a-chains during cardiogenesis (Roman and McDonald, 1992; Terracio et al., 1991; Korhonen et al., 1990) .
To fully understand the role of integrin-mediated cell-ECM interactions during normal heart development and disease processes, it will be necessary to elucidate the roles of individual ECM components and their specific receptors. Developmental perturbation experiments utilizing microinjection of antibodies and anti-sense oligonucleotides in cell and whole-embryo culture are currently under way in an attempt to isolate specific roles for several ECM components.
